The R-diastereomer of phosphorothioate analogs of cGMP, Rp-cGMPS, is one of few known inhibitors of cGMP-dependent protein kinase I (PKG I); however, its mechanism of inhibition is currently not fully understood. Here, we determined the crystal structure of the PKG Ib cyclic nucleotide-binding domain (PKG Ib CNB-B), considered a 'gatekeeper' for cGMP activation, bound to Rp-cGMPS at 1.3 A. Our structural and NMR data show that PKG Ib CNB-B bound to Rp-cGMPS displays an apo-like structure with its helical domain in an open conformation. Comparison with the cAMP-dependent protein kinase regulatory subunit (PKA RIa) showed that this conformation resembles the catalytic subunit-bound inhibited state of PKA RIa more closely than the apo or Rp-cAMPS-bound conformations. These results suggest that Rp-cGMPS inhibits PKG I by stabilizing the inactive conformation of CNB-B.
equatorial exocyclic sulfur instead of oxygen and due to their antagonistic effects are predicted to bind the cyclic nucleotide pockets without inducing the conformational changes required for kinase activation. Furthermore, structural studies of interactions with PKA and Rp-cAMPS suggest that Rp-cAMPS acts as an inverse agonist to increase the interaction between the R-and C-subunits [13] . Rp-cAMPS selectively binds the CNB domains in a C-subunit-bound conformation for its antagonist effect [13] . NMR studies on RpcAMPS interactions with PKA and exchange protein activated by cAMP showed that Rp-cAMPS binding alters the allosteric network within the CNB domains and ultimately prevents the propagation of the activation signal out of the domain [7, 8, 14] . In PKA in particular, Rp-cAMPS binding makes the PBC and adjacent b2-3 more dynamic compared to cAMP-or Sp-cAMPS (the S-diastereomer)-bound states and, unlike cAMP, stabilizes the inactive state of the CNB-A [7, 8] . This similarity between the apo and RpcAMPS-bound state in PKA has also been confirmed by hydrogen deuterium exchange mass spectrometry [13] .
Recent structural studies highlight the critical role of cGMP binding to CNB-B in activation of PKG I [15, 16] . Studies showed that binding of cGMP to The PBC is colored in yellow, the aB helix is in red, the N-terminal helices are in teal, and the b barrel is in tan. Rp-cGMPS is colored by atom type. The N and C termini are labeled with their corresponding residue numbers seen in the final model. Rp-cGMPS is shown as sticks, except for sulfur which is highlighted with purple dots. The atoms are colored as follows: carbons in cGMP, white; oxygen, red; nitrogen, blue; sulfur, purple. Inset shows the bound Rp-cGMPS with an |F o ÀF c | omit map (contoured at 1.0 r level). (C) Structural comparison with the apo state. The Rp-cGMPS bound colored in red is shown on left and the apo colored in gray is shown on right. The disordered b4-b5 loop is indicated with a dotted line. Two structures are aligned at the b-barrel region and shown in the middle panel. (D) Structural comparison with the cGMP-bound state. The Rp-cGMPS is, colored red and the cGMP bound, colored tan. The middle panel shows their alignment. All structure images were generated using PyMOL (Schr€ odinger, LLC).
CNB-B is required for the large conformational changes associated with the full activation of PKG I [15] . This domain is about 200-fold more selective for cGMP compared to cAMP. Mutating key cGMP contact residues in CNB-B significantly increases activation constants for the full-length PKG I, demonstrating its critical role in cGMP selective activation [15] . Thus, these findings suggest that RpcGMPS binding to CNB-B is critical for the inhibition of PKG I. Rp-cGMPS inhibits activation of native PKG I with a K i value of 20 lM [17] . However, with no structural information describing the PKG-RpcGMPS interaction available, its inhibition mechanism is currently not known.
Materials and methods
Protein expression, purification, and crystallization PKG Ib 219-351 was expressed and purified as previously described for PKG Ib (219-369) [15, 18] . Sequences encoding PKG Ib 219-369 were cloned into pQTEV using a template containing full-length PKG Ib (GenBank ID ABQ59040.1, coding for UniProt protein sequence Q13976-2). The purity of the resulting samples was analyzed by SDS/PAGE. For surface plasmon resonance (SPR) measurement, the hepta-histidine tag was not cleaved, prior to the size exclusion chromatography step. The crystallization was performed using the hanging drop method and 400 nL drops. The crystallization solution (0.8 M lithium sulfate monohydrate, 0.1 M sodium acetate trihydrate, pH 4.0, 4% (v/v) polyethylene glycol 200) was mixed 1 : 1 with freshly purified protein at 50 mgÁmL À1 with 10 mM Rp-cGMPS.
Crystals grew at 4°C within a week. Crystals were cryoprotected for 5 min in the crystallization condition supplemented with 33% ethylene glycol and then flash frozen in liquid nitrogen. Diffraction experiments were performed at the Advanced Light Source (Berkeley, CA). Data were processed using iMOSFLM and resolution limits were set based on CC 1/2 [19, 20] . Molecular replacement was performed using PHASER and apo PKG Ib CNB-B structure (PDB ID: 4KU8) as a search model [21] . Models were manually built and refined using PHENIX and COOT [22, 23] . The experimental structure factors and refined coordinates have been deposited in the Protein Data Bank (PDB) with accession code 5L0N.
NMR spectroscopy
Samples of apo, Rp-cGMPS-bound, and cGMP-bound PKG Ib (219-369) were prepared in 50 mM Tris, pH 7.0, 100 mM NaCl, 1 mM DTT, and 0.02% (w/v) NaN 3 N-acetylglycine as an internal reference for spectrum alignment [24] . Sufficient concentrations of Rp-cGMPS and cGMP were used to achieve saturated ligand binding, i.e., > 1 mM, thus minimizing the influence of differing ligand affinities on the final analysis. All NMR spectra were acquired at 306 K with a Bruker Avance 700-MHz NMR spectrometer equipped with a 5 mm TCI cryoprobe. The spectra were processed with NMRPipe, and analyzed using Sparky [24, 25] . Peak assignments were obtained from standard three-dimensional triple-resonance NMR spectra (i.e., HNCACB, CBCA(CO)NH, HNCA, HN(CO)CA), using the automated PINE-NMR server to facilitate the assignment process [26] .
Surface plasmon resonance
Surface plasmon resonance experiments were performed on a Pioneer FE (Oklahoma City, OK, USA) using OneStep TM injections.
OneStep TM injections create a continuous concentration gradient of analyte during the association phase and are a reliable alternative to fixed concentration injections [27, 28] . Instead of a full dilution series as with other SPR instrumentation, OneStep TM injections generate analyte concentrations gradients which fully characterize kinetic and affinity interactions. A his-tagged PKG Ib CNB-B (219-351) surface was prepared using standard Ni-NTA capture-coupling protocols and amine coupling with HisCap chips (SensiQ Technologies) [29] . A surface of 3400 RU was generated to minimize mass transport and rebinding artifacts. OneStep TM injections were performed in triplicate from 0 to 10 lM cGMP and 0 to 100 lM RpcGMPS using HBS-T buffer (10 mM HEPES, pH 7.5, 150 mM NaCl, and 0.005% Tween-20) at a flow rate of 60 lLÁmin À1 using 50% of the dispersion loop volume.
Sucrose [3% (w/v)] was also prepared in running buffer as a diffusion standard. Double referenced, experimental data were fit to a mass transport limited model using QDAT software (SensiQ Technologies). No mass transport was observed in the Rp-cGMPS curves.
Kinase activity assays
Kinase activity was determined using a microfluidic mobility-shift assay on a Caliper DeskTop Profiler (PerkinElmer, Waltham, MA, USA), as previously described [18] . Activation of PKG Ib in dependence of cGMP or RpcGMPS, respectively, was determined. cGMP activates PKG with an activation constant (K a ) of 537 AE 10 nM (n = 2), while PKG Ib remains inactive in the presence of incubated with 1 lM cGMP and various concentrations of Rp-cGMPS in assay buffer in a 384-well assay plate for 2 h and substrate conversion was determined as described above. Substrate conversion was plotted against the logarithmic cyclic nucleotide concentration, and activation constants (K a ) and inhibition constants (K i ) were determined from sigmoidal dose-response curves employing GRAPHPAD PRISM 6.01 (La Jolla, CA, USA).
Results and discussion

Structure determination
To understand how Rp-cGMPS binds CNB-B of PKG Ib, we solved a crystal structure of their complex at 1.3
A resolution ( Table 1 and Fig. 1B) . The PKG Ib CNB-B : Rp-cGMPS complex was crystallized in the P2 1 2 1 2 1 space group with one molecule per asymmetric unit. The final model includes the entire CNB-B domain used for crystallization (residues 219-351) with the exception of the aC helix (residues 344-351), due to missing electron density. Within its cGMP pocket, there is clear electron density for Rp-cGMPS and a neighboring sulfate molecule, due to the high sulfate in the crystallization solution. The structure shows the CNB-B domain in an apo-like conformation when bound to Rp-cGMPS [15] (Fig. 1C) . It shows an open PBC interacting with the N3A motif (in), while the aB helix at the C-terminal positions away (up) from the PBC and the aC helix is disordered as seen in the apo structure (PDB ID: 4KU8). This contrasts the cGMPbound conformation where the PBC becomes more compact (closed), the aB/C helices come down toward the PBC (down) as the aC helix becomes ordered and N3A moves away from the PBC (out) [15] (Fig. 1D) .
Detailed interactions of the PBC residues
Although interactions with Rp-cGMPS, especially between the guanine moiety and base-binding region, are almost identical to those seen when cGMP bound, the Rp-cGMPS structure shows significant rearrangement of the hydrogen bonding pattern for PBC residues compared to those seen in the apo and cGMP-bound conformations (Fig. 2) . Firstly, the helical region of the PBC (aP) no longer interacts with Rp-cGMPS and the loop region of PBC, allowing the open conformation ( Fig. 2A) . In both cGMP-and cAMP-bound structures, the exposed backbone atoms of aP provide strong hydrogen bonds with Arg316 and cyclic nucleotides at the loop of the PBC, stabilizing the closed conformation [15] (Fig. 2B ). These include a hydrogen bond between the backbone amide of Ala309 and the equatorial exocyclic oxygen.
Additionally, the backbone carbonyl of Gly307 forms a hydrogen bond with the side chain of Arg316, which also binds the equatorial exocyclic oxygen of cyclic nucleotides. In the Rp-bound conformation, replacing the equatorial exocyclic oxygen with sulfur disrupts these hydrogen bonds, leading to an opening of the PBC, similar to what is seen in the apo structure [15] (Fig. 2B, middle panel) . The Rp-cGMPS bound structure shows aP stretched away from the loop region of the PBC with the backbone atoms of Gly306 and Ala309 located 4
A away from the side chain of Arg316 and the equatorial exocyclic sulfur, respectively. Secondly, the structure shows that Glu307 no longer interacts with the ribose, but alternately with Gln311 through hydrogen bonds (Fig. 2) . In the cGMP-bound conformation, the side chain of Glu307 forms a hydrogen bond with 2 0 OH of the ribose, while the side chain of Gln311 interacts with the side chain of Lys308. In addition, a sulfate anion occupies the same site that Glu307 in the cGMP-bound structure used to occupy and interacts with the ribose and Trp304 through hydrogen bonds (Fig. 2B ). In the cGMP-bound conformation, the side chain of Lys308 points downward interacting with the side chains of Gln311 (PBC) and the backbone carbonyl of Lys349 (the C-terminal loop) through hydrogen bonds stabilizing the closed PBC [15] . In the apo structure, the side chain of Lys308 points toward solvent without any interacting partner while the side chain of Gln311 is disordered [15] (Fig. 2B, left panel) . In major contrast, the side chain of Lys308 flips toward the helical tip of the PBC, forming hydrogen bonds with the backbone carbonyl atoms of Glu313 and Val315 further stabilizing the open PBC in the RpcGMPS-bound state.
NMR studies
To further investigate if this apo-like conformation exists in the presence of Rp-cGMPS in solution, we turned to NMR. Backbone assignments were obtained for selected, representative PBC residues (Fig. 3) . Although complete assignment of the PBC in all three forms (i.e., apo, cGMP-, and Rp-cGMPS-bound) was not possible for all PBC amino acids due to linebroadening and/or peak overlap, the assigned NMR cross-peaks indicate that in solution, the Rp-bound PBC exists in a distinct conformation from that of the cGMP-bound state [30] . For example, Ala309 showed a proton shift from~8.5 p.p.m. tõ 7.7 p.p.m. when bound to Rp-cGMPS, consistent with the loss of the interaction between its backbone amide and the equatorial oxygen of cGMP and in agreement with our previous X-ray and joint X-ray/ neutron crystal structures [15, 18] (Fig. 3A) . Gly306, Glu307, and Gln311 also showed clear cross-peaks at intermediate positions between the apo (inactive) and cGMP (active) cross-peaks (Fig. 3B-E) . Considering that exchange between the inactive and active states is fast on the chemical shift NMR time scale, the intermediate position of the Rp cross-peak between apo and cGMP points to a net shift in the Rp bound toward the inactive apo state [30] . These results strongly support that in solution, Rp-cGMPS stabilizes the inactive apo-like conformation better than cGMP. However, it also shows that the conformational ensemble of the Rp-cGMPS-bound CNB-B in solution might include a subset of active-state conformers. These data agree with previous cyclic phosphorothioate NMR experiments, which found that Rp-cAMPS partially shifts the conformational equilibrium of the cAMP-binding domain-A of PKA toward an inhibitory C-bound like structure [7, 31] . 
Affinity and inhibition constant
To investigate how these changes in interactions with Rp-cGMPS affect the affinity, we determined the equilibrium dissociation constant (K D ) of Rp-cGMPS and cGMP for PKG Ib CNB-B using surface plasmon resonance (SPR) ( Table S1 ). In agreement with previously reported competition-based SPR and fluorescence polarization assays, PKG Ib CNB-B showed a K D of 108 nM for cGMP [15] (Fig. S1A-B) . As for RpcGMPS, a K D value of 8.8 lM was determined, representing~81-fold reduction in its affinity compared to cGMP (Fig. S1B) . This is consistent with the loss of key hydrogen bonds as seen in the structure and NMR. Our data also showed that Rp-cGMPS does not activate the full-length PKG Ib (residues 5-686) even at as high as 3 mM confirming its role as an inhibitor [17] (Fig. S1C,  D) . Finally, we determined its K i value to be 49 lM using microfluidic mobility-shift assay (Fig. S1E) . This value is similar to what previous reported using a radiolabeled ATP assay [17] .
Conclusions about inhibition mechanism
The cocrystal structure of PKG Ib : Rp-cGMPS reveals that Rp-cGMPS stabilizes an inactive conformation with a distinctly rearranged hydrogen bonding pattern between PBC residues, which is unseen in either apo or cGMP-bound conformations [15] . Its comparison with PKA RIa CNB domain suggests that the stabilization of the open PBC upon Rp-cGMPS binding is a unique feature in PKG Ib (Fig. 4A) . Due to the lack of structural information for the R-C complex which represents an inhibited state of PKG I, we compared PKG Ib CNB-B : Rp-cGMPS complex with structures of PKA RIa CNB-B [32]. Interestingly, this comparison revealed that the PKG Ib CNB-B : Rp-cGMPS complex assumes a conformation that resembles the C-subunit-bound conformation of PKA RIa CNB-B domain, and not the apo or Rp-cAMPS bound. In fact, the apo and Rp-cAMPSbound structures showed an active conformation similar to the cAMP-bound structure. Sequence comparison at the PBC shows indeed that PKA RIa lacks key PBC residues that stabilize the inactive state, suggesting that this is a unique feature for PKG Ib (Fig. 4B) . In summary, our structure combined with NMR data suggests that Rp-cGMPS inhibit PKG by locking CNB-B in the inactive conformation keeping the kinase inhibited. 
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